Megestrol Acetate USP

Composition: Each ml suspension contains Megestrol Acetate USP 40mg.

Indications: lt is indicated for the treatment of anorexia, cachexia, or an unexplained, significant

weight loss in patients with a diagnosis of acquired immunedeficiency syndrome (AIDs) & cancer.

Dosage and administration: The recommended adult initial dosage is 800 mg/day (20 ml/day). The bottle should be shaken well before use. Or, as directed by the registered physician.

Use in pregnancy and lactation: Pregnancy category X. There are no adequate and well controlled studies of Megestrol administration in pregnant Women. It is a progesterone derivative, which may induce vaginal bleeding in women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Because of the potential for adverse effects on the newborn, nursing should be discontinued if Megestrol oral suspension is required.

Packing: Each bottle contains 100ml oral suspension.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.